13d
Zacks Small Cap Research on MSNMGRM: Monogram Receives Clearance from the FDA on its 510(k) Submission for its mBôs TKA System.MGRM READ THE FULL MGRM RESEARCH REPORT On March 17, 2025, Monogram (NASDAQ:MGRM) announced that the FDA has granted 510(k) clearance for its Monogram mBôs TKA System. This determination means that ...
Ben Sexson, Monogram Chief Executive Officer, commented, "This FDA 510(k) clearance is a defining moment for Monogram. It marks the culmination of years of relentless effort, innovation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results